Harmonex, Inc. – Trademark Portfolio
Entity Type: 03
Harmonex, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CLINICOM. The owner is based in Dothan, AL.
408 Healthwest Drive
Dothan, AL 36303
Showing of trademarks Trademarks
Trademark Classifications
Harmonex, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Harmonex, Inc. have?
Harmonex, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Harmonex, Inc. file in?
Harmonex, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Harmonex, Inc.'s most well-known trademarks?
Harmonex, Inc.'s registered trademark portfolio includes well-known marks such as CLINICOM. These are among 2 currently registered trademarks in the portfolio.
What is Harmonex, Inc.'s trademark registration success rate?
Harmonex, Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.